Alyeska Investment Group, L.P. Synlogic, Inc. Transaction History

Alyeska Investment Group, L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.56 - $1.07 $101,667 - $194,257	-181,549 Reduced 6.72%	2,520,514 $1.59 Million
Q4 2022 Feb 14, 2023	SELL	$0.58 - $17.99 $575,135 - $17.8 Million	-991,613 Reduced 26.85%	2,702,063 $2.05 Million
Q3 2022 Nov 14, 2022	BUY	$0.91 - $14.63 $451,564 - $7.26 Million	496,225 Added 15.52%	3,693,676 $3.51 Million
Q2 2022 Aug 15, 2022	BUY	$0.89 - $2.47 $539,790 - $1.5 Million	606,506 Added 23.41%	3,197,451 $3.68 Million
Q1 2022 May 16, 2022	BUY	$1.63 - $2.55 $121,009 - $189,309	74,239 Added 2.95%	2,590,945 $6.22 Million
Q4 2021 Feb 14, 2022	BUY	$2.27 - $3.0 $1.05 Million - $1.38 Million	460,413 Added 22.39%	2,516,706 $6.09 Million
Q3 2021 Nov 15, 2021	BUY	$2.45 - $4.1 $3.08 Million - $5.15 Million	1,256,293 Added 157.04%	2,056,293 $6.27 Million
Q2 2021 Aug 16, 2021	BUY	$3.0 - $4.39 $2.4 Million - $3.51 Million	800,000 New	800,000 $3.11 Million

25.5K

Ticker SYBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,229,600
Market Cap $103M
Description
Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase I...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.